COH – JP Morgan rates the stock as Underweight

By Broker News | More Articles by Broker News

Significant expansion of multiples since the FY14 results means the stock is now on a FY15 price/earnings ratio of 32 times which JP Morgan finds difficult to justify, given the intensifying competition.

The broker retains an Underweight rating but is on the watch for a favourable resolution of CMS reimbursement issues, while processor upgrades will be an important metric in the first half. Target is raised to $61.70 from $58.15.

Sector: Health Care Equipment & Services.

Target price is $61.70.Current Price is $83.36. Difference: ($21.66) – (brackets indicate current price is over target). If COH meets the JP Morgan target it will return approximately -35% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →